Solid Biosciences Inc. SLDB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$191.78M-37.3% | -$174.33M-39.8% | -$167.14M-63.2% | -$154.08M-69.9% | -$139.68M-54.8% | ||
| $1.62M-35.9% | $1.64M-33.4% | $1.66M-36.6% | $1.69M-40.9% | $2.54M+12.0% | ||
| $18.73M+52.9% | $16.91M+60.8% | $14.24M+64.8% | $13.3M+83.1% | $12.25M+72.1% | ||
| $767K-76.5% | -$1.09M-150% | $4.98M— | $2.2M— | $3.26M— | ||
| $3.85M-10.0% | $4.05M-15.0% | $5.52M+269% | $6.63M— | $4.28M— | ||
| —— | —— | —— | —— | —— | ||
| $217K+147% | $239K+172% | $261K+1,049% | -$11K+92.3% | $88K+134% | ||
| -$1.87M-15.3% | -$1.79M-6.6% | -$1.71M+1.8% | -$1.66M+6.8% | -$1.62M— | ||
| -$171.67M-60.9% | -$156.29M-56.3% | -$132.38M-45.2% | -$122.62M-43.6% | -$106.67M-16.7% | ||
| $1.19M+88.9% | $1.15M+76.3% | $792K+46.7% | $722K-20.5% | $631K-45.5% | ||
| $254.01M+36.3% | $235.89M+15.4% | $227.29M+11.6% | $229.58M+50.6% | $186.33M— | ||
| —— | —— | —— | —— | —— | ||
| $588K-3.3% | $723K+52.9% | $648K— | $525K— | $608K— | ||
| —— | —— | —— | $303K— | $306K— | ||
| $245.35M+19.7% | $196.05M+60.1% | $197.84M+70.6% | $199.92M— | $204.92M— | ||
| $85.84M— | -$20.3M— | -$3.04M— | $43.09M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.18M-35.2% | $1.87M-47.8% | $1.93M-51.0% | $2.81M-24.4% | $3.36M+23.1% | ||
| -$6.05M-295% | -$6.05M-227% | $1.35M— | $2.2M— | $3.1M— | ||
| —— | $0-100% | $500K-66.7% | $1M0.0% | $1.5M+200% | ||
| $3.85M-10.0% | $4.05M-15.0% | $5.52M+269% | $6.63M— | $4.28M— | ||
| -$1.87M-15.3% | -$1.79M-6.6% | -$1.71M+1.8% | -$1.66M+6.8% | -$1.62M— | ||
| —— | —— | —— | —— | —— | ||
| $2.42M+4.9% | $2.37M-0.8% | $2.33M-6.1% | $2.31M-8.4% | $2.31M— | ||
| $217K+147% | $239K+172% | $261K+1,049% | -$11K+92.3% | $88K+134% | ||
| -$268.88M-47.8% | -$178.5M+5.5% | -$161.1M+17.3% | -$197.6M-51.7% | -$181.9M-33.9% | ||
| —— | —— | —— | $1.68M— | $20K— | ||
| $12.89M— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | $189.64M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $588K-3.3% | $723K+52.9% | $648K— | $525K— | $608K— | ||
| —— | —— | $293K+162% | -$20K+55.6% | $60K— | ||
| —— | —— | —— | —— | $5M— | ||
| -$1.87M-15.3% | -$1.79M-6.6% | -$1.71M+1.8% | -$1.66M+6.8% | -$1.62M— | ||
| —— | $0+100% | -$65.25K+74.8% | -$130.5K+49.1% | -$195.75K+23.0% | ||
| —— | $4.18M-2.1% | $4.2M-2.9% | $4.22M-3.7% | $4.24M-4.5% | ||
| —— | $0— | —— | —— | —— | ||
| —— | $91K-80.6% | $185.5K-58.4% | $280K-33.6% | $374.5K-6.0% | ||
| —— | $723K+113% | $627.25K— | $531.5K— | $435.75K— | ||
| -$172.86M-61.1% | -$157.44M-56.4% | -$133.17M-45.2% | -$123.34M-42.9% | -$107.3M-16.0% | ||
| -$172.86M-61.1% | -$157.44M-56.4% | -$133.17M-45.2% | -$123.34M-42.9% | -$107.3M-16.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
